M DAROLUTAMIDE (is an active metabolite) | DAROLUTAMIDE | ATC L02BB06
ANTINEOPLASTIC ANDROGEN RECEPTOR INHIBITOR TREATMENT OF NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER | - | PPB 99.8 PERCENT HT 20 HOUR | ANDROGEN RECEPTOR (AR) | Androgen receptor UNIPROT P10275 AR more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |